A new terrein glucoside, a novel inhibitor of angiogenin secretion in tumor angiogenesis

Journal of Antibiotics

Volumn 61, Issue 7, 2008, Pages 442-448

  Arakawa, Masayuki ^a   Someno, Tetsuya ^a   Kawada, Manabu ^a   Ikeda, Daishiro ^a  

^a Numazu Bio Medical Research Institute   (Japan)

Author keywords

Angiogenesis; Angiogenic factors; Angiogenin; Prostate cancer; Terrein glucoside

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIN; GLUCOSIDE; TERREIN; TERREIN ALPHA DEXTRO GLUCOSIDE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CYCLOPENTANE DERIVATIVE; PANCREATIC RIBONUCLEASE;

ANTIANGIOGENIC ACTIVITY; ARTICLE; ASPERGILLUS; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ISOLATION; FUNGAL STRAIN; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; STEREOCHEMISTRY; TUMOR VASCULARIZATION; CHEMISTRY; DRUG ANTAGONISM; ENDOTHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; SECRETION; TUMOR CELL LINE;

ASPERGILLUS SP.;

ANTINEOPLASTIC AGENTS; ASPERGILLUS; CELL LINE, TUMOR; CULTURE MEDIA; CYCLOPENTANES; ENDOTHELIAL CELLS; GLUCOSIDES; HUMANS; INHIBITORY CONCENTRATION 50; RIBONUCLEASE, PANCREATIC;

EID: 55449094931     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2008.60     Document Type: Article

References (22)

1. Berger G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nature Reviews Cancer 3: 401-410 (2003)
2. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18 (2002)
3. Folkman J. Angiogenesis and angiogenesis inhibition: an overview. EXS 79: 1-8 (1997)
4. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nature Reviews Cancer 2: 795-803 (2002)
5. Chiarugi V, Magnelli L, Gallo O. Cox-2, iNOS and p53 as play-markers of tumor angiogenesis. Int J Mol Med 2: 715-719 (1998)
6. Singh RP, Agarwal R. Prostate cancer prevention by silibinin. Current Cancer Drug Targets 4: 1-11 (2005)
7. Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Int J Cancer 118: 1635-1644 (2006)
8. Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochem 24: 5480-5486 (1985)
9. Shapiro R, Riordan JF, Vallee BL. Characteristic ribonucleolytic activity of human angiogenin. Biochem 25: 3527-3532 (1986)
10. Yoshioka N, Wang Li, Kishimoto K, Tsuji T, Hu G. A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc Natl Acad Sci USA 103: 14519-14524 (2006)
11. Horner JJ, Greenman J, Stafford ND. Angiogenic cytokines in serum and plasma of patients with head and neck squamous cell carcinoma. Clin Otolaryngol Allied Sci 25: 570-576 (2000)
12. Verstovsek S, Kantarjian H, Aguayo A, Manshouri T, Freireich E, Keating M, Estey E, Albitar M. Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome. Br J Haematol 114: 290-295 (2001)
13. Zhao H, Grossman HB, Delclos GL, Hwang LY, Troisi CL, Chamberlain RM, Chenoweth MA, Zhang H, Spitz MR, Wu X. Increased plasma levels of angiogenin and the risk of bladder carcinoma: from initiation to recurrence. Cancer 104: 30-35 (2005)
14. Kawada M, Inoue H, Usami I, Takamoto K, Masuda T, Yamazaki Y, Ikeda D. Establishment of a highly tumorigenic LNCaP cell line having inflammatory cytokine resistance. Cancer Lett 242: 46-52 (2006)
15. Kawada M, Inoue H, Arakawa M, Takamoto K, Masuda T, Ikeda D. Highly tumorigenic human androgen receptor-positive prostate cancer cells overexpress angiogenin. Cancer Sci 98: 350-356 (2007)
16. Miwa I, Okuda J, Maeda K, Okuda G. Mutarotase effect on colorimetric determination of blood glucose with -D-glucose oxidase. Clin Chim Acta 37: 538-540 (1972)
17. Kolb HC, Hoffman MR. A total synthesis of racemic and optically active terrein (trans-4,5-dihydroxy-3-[(E)-1-propenyl]-2-cyclopenten-1- one). Tetrahedron: Symmetry 1: 237-250 (1990)
18. Raistrick H, Smith G. Biochemistry of microorganisms. XLII. The metabolic products of Aspergillus terreus Thorn: a new mold metabolic product-terrein. Biochem J 29: 606-611 (1935)
19. Kawakubo J, Nishira H, Aoki K, Shinke R. Production of phenolic compounds by Aspergillus S-4 in sake-cake medium and identification of terrein. Biosci Biotec Biochem 57: 1208-1209 (1993)
20. Park SH, Kim DS, Kim WG, Ryoo IJ, Lee DH, Huh CH, Youn SW, Yoo ID, Park KC. Terrein: a new melanogenesis inhibitor and its mechanism. Cell Mol Life Sci 61: 2878-2885 (2004)
21. Kim DS, Cho HJ, Lee HK, Lee WH, Park ES, Youn SW, Park KC. Terrein, a fungal metabolite, inhibits the epidermal proliferation of skin equivalents. J Dermatol Sci 46: 65-68 (2007)
22. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24: 445-456 (2005)